TrialBlood advances2020
Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm.
Naveen Pemmaraju et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papercites it
TrialBlood advances2020
Naveen Pemmaraju et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.